[EN] PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS<br/>[FR] COMPOSÉS DE PYRIDIN-2-ONE UTILES EN TANT QU'ANTAGONISTES DE SMARCA2
申请人:EPIZYME INC
公开号:WO2020023657A1
公开(公告)日:2020-01-30
This disclosure generally relates to pyridine-2-one compounds of formula (I) and methods of using them in the treatment of a disorder, such as cancer or a SMARCA2-associated disorder, including as antagonists (e.g., inhibitors) of SMARCA2. The present disclosure provides treatment modalities, e.g., strategies, treatment methods, patient stratification methods, compounds, combinations, and compositions that are useful for the treatment of disorders, e.g., proliferative disorders, such as certain cancers. Some aspects of this disclosure provide treatment modalities, methods, strategies, compounds, compositions, combinations, and dosage forms for the treatment of cell proliferative disorders, e.g., cancers with decreased activity or function, or loss of function, of SMARCA4 with a SMARCA2 antagonist.